Patanase FDA Approved Drugs
OLOPATADINE HYDROCHLORIDE [Olopatadine HydrochlorideC21H23NO3ClH]
RX
- 0.665mg/spray (nasal spray, metered)
eq 0.1% base (ophthalmic solution/drops)
eq 0.2% base (ophthalmic solution/drops)
Apotex IncOct 8, 2014
Perrigo IsraelJan 31, 2017
Akorn IncJan 10, 2017
Aurobindo Pharma LtdDec 18, 2015
Somerset Theraps LlcDec 7, 2015
Usv North AmericaDec 7, 2015
Wockhardt LtdJun 28, 2017
Zach System SpaDec 7, 2015
Barr Labs IncJul 13, 2015
Perrigo IsraelJan 31, 2017
Akorn IncJan 10, 2017
Aurobindo Pharma LtdDec 18, 2015
Somerset Theraps LlcDec 7, 2015
Usv North AmericaDec 7, 2015
Wockhardt LtdJun 28, 2017
Zach System SpaDec 7, 2015
Barr Labs IncJul 13, 2015
PATADAY [Olopatadine HydrochlorideC21H23NO3ClH]
RX
- eq 0.2% base (ophthalmic solution/drops)
Novartis Pharms CorpDec 22, 2004
- Method of treating allergic conjunctivitis.
PATANASE [Olopatadine HydrochlorideC21H23NO3ClH]
RX
- 0.665mg/spray (nasal spray, metered)
Novartis Pharms CorpApr 15, 2008
- Allergic rhinitis.
PATANOL [Olopatadine HydrochlorideC21H23NO3ClH]
RX
- eq 0.1% base (ophthalmic solution/drops)
Novartis Pharms CorpDec 18, 1996
PAZEO [Olopatadine HydrochlorideC21H23NO3ClH]
RX
- eq 0.7% base (ophthalmic solution/drops)
Novartis Pharms CorpJan 30, 2015
- Treatment of ocular itching associated with allergic conjunctivitis.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.